LLY Financial Facts

Cost of sales, operating expenses, and other-net: 4.22B
Asset impairments, restructuring, and other special charges: 45.5M
See Full Income Statement

Common stock: 690.4M
Long-term debt: 8.71B
See Full Balance Sheet

Eli Lilly (LLY) Earnings

  |   Expand Research on LLY
Next EPS Date 1/31/17 EPS Growth Rate +24.4%
Average EPS % Beat Rate -2.4% Revenue Growth Rate +3.0%
Average % Move 1-Wk after EPS -2.9% Normal Earnings Time Before Open
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
1/31/17 Q416 N/A$0.97 N/A N/A$5.54B N/A N/A N/A
10/25/16 Q316 $0.88$0.95 -$0.07$5.19B$5.29B N/A Details
7/26/16 Q216 $0.86$0.86 $0.00$5.4B$5.15B N/A Details
4/26/16 Q116 $0.83$0.85 -$0.02$4.87B$4.82B N/A Details
1/28/16 Q415 $0.78$0.78 $0.00$5.38B$5.32B N/A Details
10/22/15 Q315 $0.89$0.75 +$0.14$4.96B$4.99B Details
7/23/15 Q215 $0.90$0.74 +$0.16$4.98B$4.89B Details
4/23/15 Q115 $0.87$0.76 +$0.11$4.64B$4.62B Details